This clinical trial studies a web-based, cardiovascular risk tool in patients with prostate cancer. Cardiovascular (CV) disease is highly prevalent, and often represents a source of morbidity and/or mortality in excess of cancer-related risk in patients with prostate cancer. The web-based tool educates patients of CV risks in prostate cancer and to inform them of individualized, estimated CV risk and guideline-based risk mitigation recommendations. Using the web-based tool may help researchers better understand both the burden of CV risk across the prostate cancer treatment spectrum and the gaps in access to adequate treatment of CV risk factors.
Additional locations may be listed on ClinicalTrials.gov for NCT06064149.
See trial information on ClinicalTrials.gov for a list of participating sites.
PRIMARY OBJECTIVE:
I. To evaluate the feasibility and acceptability of a pragmatic, patient-oriented, web-based application that enables the education of patients regarding CV risks and collects CV and prostate cancer-related risk variables and CV care access data from prostate cancer patients receiving androgen deprivation therapy (ADT).
SECONDARY OBJECTIVES:
I. To evaluate the data quality of the web-based application among prostate cancer patients receiving ADT.
II. To preliminarily assess the impact of the web-based application on CV care access and risk mitigation among men with prostate cancer receiving ADT.
OUTLINE:
Patients use the CARE-PC application tool website and receive tailored, guideline-supported recommendations on strategies to help reduce the patient’s risk of future CV disease.
After completion of study intervention, patients are followed up at 6 months.
Trial PhaseNo phase specified
Trial Typehealth services research
Lead OrganizationUniversity of Pennsylvania/Abramson Cancer Center
Principal InvestigatorVivek K. Narayan
